sarpogrelate has been researched along with aspirin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Ozaki, Y; Shimasaki, AK | 1 |
| Fujita, M; Ho, M; Ishii, K; Miki, O; Miwa, K; Miyamoto, A; Mizuno, K; Tsukahara, R | 1 |
| Ishizuka, T; Ito, S; Mori, T; Nako, K; Ogawa, S | 1 |
| Fukuuchi, Y; Gotoh, F; Handa, S; Hayashi, K; Hirai, S; Kobayashi, S; Kondo, K; Nishimaru, K; Otomo, E; Sawada, T; Shinohara, Y; Terashi, A; Tohgi, H; Uchiyama, S; Yamaguchi, T | 1 |
| Nishimaru, K; Shinohara, Y | 1 |
| Chi, HS; Kim, H; Kim, KM; Kim, SB; Park, JS | 1 |
| Diener, HC; Weber, R | 1 |
| Kajiwara, I; Miyamoto, S; Ogawa, H; Soejima, H | 1 |
| Cha, BY; Kim, YS; Kwon, HS; Lee, HC; Lee, HJ; Oh, S; Park, SY; Rhee, SY | 1 |
| Nagai, H; Nakagawa, H; Niki, H; Nishikawa, M; Yamada, K | 1 |
| Kamal, AK; Shaikh, Q | 1 |
| Inuyama, L; Mizuno, O; Sakaguchi, T; Takahashi, S; Yamada, T | 1 |
| Chae, IH; Cho, YS; Choi, DJ; Kim, HS; Kim, SH; Lee, SA; Park, JJ; Suh, JW; Yoon, CH; Youn, TJ | 1 |
| Bae, SK; Kim, GJ; Kim, JH; Lee, J; Lee, S; Lim, HS; Noh, Y; Oh, E; Shin, S | 1 |
| Gu, Y; Guo, J; Guo, L; Qi, L; Tong, Z; Wang, Z; Yu, H; Zhang, J | 1 |
| Lee, J; Park, S; Seo, JH; Shin, KJ | 1 |
| Chun, EJ; Han, SJ; Hur, JH; Jang, HC; Kang, DK; Kim, HJ; Kim, KM; Lee, DH; Lee, JE; Lim, S; Min, SH; Oh, TJ | 1 |
| Ahn, S; Cho, MJ; Cho, S; Ha, J; Kim, SY; Lee, J; Min, SI; Min, SK | 1 |
| Cho, YP; Gwon, JG; Han, A; Jung, IM; Kang, JM; Ko, H; Lee, J; Lee, SS; Lee, T; Min, SK; Park, YJ; Song, SW; Yun, WS | 1 |
1 review(s) available for sarpogrelate and aspirin
| Article | Year |
|---|---|
Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.
Topics: Aspirin; Blood-Brain Barrier; Cilostazol; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy, Combination; Humans; Lactones; Naphthalenes; Platelet Aggregation Inhibitors; Propionates; Pyridines; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Succinates; Tetrazoles; Thrombosis; Ticlopidine | 2010 |
9 trial(s) available for sarpogrelate and aspirin
| Article | Year |
|---|---|
Sarpogrelate treatment reduces restenosis after coronary stenting.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cell Division; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Prospective Studies; Serotonin Antagonists; Succinates; Ticlopidine; Treatment Outcome | 2003 |
Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis Obliterans; Aspirin; Chemokine CCL2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Pioglitazone; Platelet Aggregation Inhibitors; Succinates; Thiazolidinediones | 2008 |
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Receptors, Serotonin; Secondary Prevention; Serotonin Antagonists; Succinates; Treatment Outcome | 2008 |
Sarpogrelate versus aspirin in secondary prevention of cerebral infarction: differential efficacy in diabetes? Subgroup analysis from S-ACCESS.
Topics: Aged; Aspirin; Cerebral Infarction; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Secondary Prevention; Succinates; Treatment Outcome | 2009 |
Evaluation of the effectiveness of sarpogrelate on the surrogate markers for macrovascular complications in patients with type 2 diabetes.
Topics: Adiponectin; Adult; Aged; Ankle Brachial Index; Aspirin; Biomarkers; C-Reactive Protein; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Interleukin-6; Male; Middle Aged; Succinates | 2012 |
Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Hepatic Insufficiency; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Renal Insufficiency, Chronic; Republic of Korea; Research Design; Serotonin Antagonists; Succinates; Ticlopidine | 2015 |
Effect of sarpogrelate, a selective 5-HT
Topics: Adult; Aged; Ankle Brachial Index; Anti-Inflammatory Agents; Aspirin; Biomarkers; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Insulin Resistance; Male; Middle Aged; Multidetector Computed Tomography; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Pulse Wave Analysis; Republic of Korea; Serotonin 5-HT2 Receptor Antagonists; Severity of Illness Index; Succinates; Time Factors; Treatment Outcome; Vascular Calcification | 2017 |
SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial.
Topics: Amputation, Surgical; Aspirin; Clinical Protocols; Clopidogrel; Computed Tomography Angiography; Constriction, Pathologic; Drug Therapy, Combination; Endovascular Procedures; Femoral Artery; Hemorrhage; Humans; Limb Salvage; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Popliteal Artery; Prospective Studies; Recurrence; Republic of Korea; Research Design; Risk Factors; Succinates; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency | 2017 |
A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention.
Topics: Aspirin; Clopidogrel; Delayed-Action Preparations; Drug Therapy, Combination; Femoral Artery; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prospective Studies; Treatment Outcome | 2023 |
9 other study(ies) available for sarpogrelate and aspirin
| Article | Year |
|---|---|
[Platelet aggregate formation in peripheral blood anti-coagulated with sodium heparin is facilitated by mixing].
Topics: Air; Aspirin; Blood Platelets; Heparin; Humans; Platelet Activation; Platelet Aggregation; Platelet Count; Serotonin Antagonists; Succinates | 1997 |
Comparison of antiplatelet potency of sarpogrelate, aspirin, and beraprost in healthy volunteers according to in-vitro closure time.
Topics: Adult; Aspirin; Epoprostenol; Female; Humans; Male; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Succinates | 2010 |
Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina.
Topics: Adult; Aged; Angina, Stable; Aspirin; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Plasminogen Inactivators; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin; Succinates | 2011 |
Serotonin potentiates high-glucose-induced endothelial injury: the role of serotonin and 5-HT(2A) receptors in promoting thrombosis in diabetes.
Topics: Animals; Aspirin; Cells, Cultured; Cilostazol; Diabetes Mellitus, Experimental; Fibrinolytic Agents; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Male; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Succinates; Tetrazoles; Thrombosis; Vascular Cell Adhesion Molecule-1 | 2012 |
Sarpogrelate- another new antiplatelet agent?
Topics: Aspirin; Cerebral Infarction; China; Female; Humans; Japan; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Republic of Korea; Succinates; Treatment Outcome | 2012 |
Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Cilostazol; Dipyridamole; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Secondary Prevention; Stroke; Succinates; Tablets, Enteric-Coated; Tetrazoles; Ticlopidine | 2014 |
Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database.
Topics: Aspirin; Cilostazol; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Hemorrhage; Humans; Insurance, Health; Korea; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Succinates; Tetrazoles; Ticlopidine; Treatment Outcome | 2016 |
Effects of Sarpogrelate Combined with Aspirin in Patients Undergoing Carotid Endarterectomy in China: A Single-Center Retrospective Study.
Topics: Aged; Aspirin; Blood Loss, Surgical; Carotid Stenosis; China; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hematoma; Humans; Male; Middle Aged; Operative Time; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Succinates; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Aspirination of α-Aminoalcohol (Sarpogrelate M1).
Topics: Amino Alcohols; Aspirin; Esterification; Succinates | 2016 |